Results 261 to 270 of about 121,769 (336)

Synthesis and in Vitro Characterization of 1-(4-Aminofurazan-3-yl)-5-dialkylaminomethyl-1H-[1,2,3]triazole-4-carboxylic Acid Derivatives. A New Class of Selective GSK-3 Inhibitors

, 2003
Preben H. Olesen, Anders R. Sørensen, Birgitte Ursø, Peter Kurtzhals, Andrew N. Bowler, Ulrich Ehrbar, Bo F. Hansen   +6 more
openalex   +1 more source

GSK-3 and CK2 Kinases Converge on Timeless to Regulate the Master Clock [PDF]

, 2016
Deniz Top, Emily Harms, Sheyum Syed, Eliza L. Adams, Lino Sáez   +4 more
openalex   +1 more source

Combined Effects of Depression, Fatigue and Cardiovascular Dysfunction on Functional Dependence Over Seven Years in Early Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Parkinson's disease (PD) is associated with both motor and non‐motor symptoms, which collectively impact activities of daily living (ADLs) and contribute to the loss of functional independence. There is a lack of understanding of how non‐motor symptoms drive this loss in independence.
Charlotte B. Stewart, Sahana Sathyanarayana, Victoria K. Foster, Robyn Iredale, Debra Galley, Jacopo Pasquini, Kirstie N. Anderson, Nicola Pavese, David Ledingham   +8 more
wiley   +1 more source

Regulatory Functions of Nilaparvata lugens GSK-3 in Energy and Chitin Metabolism. [PDF]

Front Physiol, 2020
Ding YJ, Li GY, Xu CD, Wu Y, Zhou ZS, Wang SG, Li C.   +6 more
europepmc   +1 more source

Synthesis of new dipyrrolo- and furopyrrolopyrazinones related to tripentones and their biological evaluation as potential kinases (CDKs1–5, GSK-3) inhibitors

, 2008
Christophe Rochais, Nghia Vu Duc, Elodie Lescot, Jana Sopková‐de Oliveira Santos, Ronan Bureau, Laurent Meijer, Patrick Dallemagne, Sylvain Rault   +7 more
openalex   +1 more source

GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder

, 2007
Michael K. Rowe, Charlotte Wiest, De‐Maw Chuang   +2 more
openalex   +1 more source

Contralateral Spread of Asymmetrical Tremor in Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Parkinsonian tremor usually starts asymmetrically. The mid‐term prognosis of this lateralized tremor is unknown, as is the development of tremor in the contralateral arm. Objective To investigate the occurrence of contralateral tremor in the Parkinson's Progression Marker Initiative database, with data available for 7 years ...
Jacopo Pasquini, Nicola Pavese, Roberto Ceravolo, Rick C. Helmich, Günther Deuschl   +4 more
wiley   +1 more source

Regulation of GSK-3: a cellular multiprocessor.

Cell, 2001
openaire   +2 more sources

Evaluating the Role of α‐Synuclein Seed Amplification as a Disease Progression Marker: Evidence and Uncertainties

Movement Disorders Clinical Practice, EarlyView.
Abstract Background α‐synuclein seeding amplification assay (α‐synuclein SAA) development as a diagnostic biomarker for Parkinson's disease (PD) has shown promising results over the past decade. However, the utility of these assays in the prediction of disease progression is unclear.
Daniel Belete, Christian Mattjie, Brook Huxford, Jonathan P. Bestwick, Alastair J. Noyce, Cristina Simonet   +5 more
wiley   +1 more source